About Us>Medical Advisory Board > H. Irene Su, MD, MSCE

H. Irene Su, MD, MSCE

Director, Fertility Preservation Program & Associate Professor, Reproductive Endocrinology, University of California San Diego

Irene Su

Highlights

  • LBBC Medical Advisory Board member since 2023
  • Director of the fertility preservation program at UC San Diego
  • Expert on infertility, reproductive aging, fertility preservation, and survivorship care
  • Research focuses on reproductive health after cancer treatment
featured_paragraph

H. Irene Su, MD, MSCE, serves as an associate professor of reproductive medicine in the division of reproductive endocrinology at the University of California, San Diego. She is also the director of the fertility preservation program.

general_content

Dr. Su, a reproductive epidemiologist, focuses on clinical areas such as infertility, reproductive aging, fertility preservation, and survivorship care. Her research centers on reproductive health post-cancer diagnosis and treatment. Beyond her clinical and research endeavors, Dr. Su enjoys discovering delightful culinary experiences, reading novels, spending quality time with her young family, and traveling to her homeland in Taiwan.

3_column_content

Experience & accolades

Expertise

  • Reproductive endocrinology
  • Fertility preservation

Education

  • University of Pennsylvania
    • Master of Science in Clinical Epidemiology
    • Fellow, Reproductive endocrinology and infertility
    • Resident, Obstetrics and gynecology
  • Albert Einstein College of Medicine, New York
    • Doctor of Medicine
  • Stanford University
    • Bachelor of Science

Experience

  • University of California San Diego
    • Professor, OBGYN & Reproductive Sciences
    • Director, Fertility Preservation Program

Awards & distinctions

  • Top Doctor, Reproductive Endocrinology and Infertility, San Diego County Medical Society, 2019
  • Top Doctor, Reproductive Endocrinology and Infertility, San Diego County Medical Society, 2013
  • Prize Paper Award, American Society of Reproductive Medicine, 2009
  • Alpha Omega Alpha Medical Honor Society, Albert Einstein College of Medicine, 2000

Publications

contributions_carousel

Contributions

Gonadotropin-releasing hormone (GnRH) agonists

10/07/19 | BY: H. Irene Su

The gonadotropin releasing hormone agonists, or GnRH agonists, are a class of injectable medicines offered to pre- and perimenopausal women with breast cancer in order to temporarily suppress, or slow, ovarian function.

Read More
 | 5 Min. Read |

Making decisions about protecting your fertility

09/06/19 | BY: H. Irene Su

You might not be thinking about having a family at the time of your diagnosis, but that’s the best time to talk with your partner, family, and healthcare team about future fertility.

Read More
 | 6 Min. Read

Protecting your fertility during treatment

08/06/19 | BY: H. Irene Su

If you are premenopausal (still having menstrual periods), breast cancer treatments such as chemotherapy and hormonal therapy can affect your fertility. This may make it harder to become pregnant after treatment ends.

Read More
 | 6 Min. Read

Birth control & breast cancer

08/05/19 | BY: H. Irene Su

If you were not in menopause before your breast cancer diagnosis and you are sexually active, it’s important to discuss birth control, or contraception, with your doctor.

Read More
 | 5 Min. Read

Am I in menopause

08/05/19 | BY: H. Irene Su

Women affected by breast cancer may be premenopausal or perimenopausal before diagnosis. Learn more about early menopause, and other ways that you may be affected.

Read More
 | 5 Min. Read

Getting pregnant after early breast cancer

12/16/15 | BY: H. Irene Su

Better breast cancer treatments are helping more women live longer. And, studies show pregnancy after breast cancer treatment doesn’t raise your risk of cancer returning or affect your survival.

Read More
 | 14 Min. Read

Fertility & metastatic breast cancer

08/31/15 | BY: H. Irene Su

Metastatic breast cancer may affect your ability and plans to have children. This section is designed to help you navigate these issues so you can make informed decisions.

Read More
 | 7 Min. Read